Bombay Blood Group: Genetic Basis, Transfusion Challenges & More

The Bombay Blood Group, also known as the hh or Oh phenotype, is one of the rarest blood groups in the human biological system. This blood group was discovered in the city of Mumbai, formerly known as Bombay, in 1952, and it defies the traditional ABO blood grouping system because of the absence of the H antigen on the red blood cells.

In case of a blood transfusion, people with this blood type can receive blood only from other H deficient donors. Because the H antigen is the precursor of the ABO blood group antigens, if it is not produced, the ABO blood group antigens are also not produced.

Historical Background

In Bombay, India, an individual was discovered to have an interesting blood type that reacted to other blood types in a way that had not been seen before.
Serum from this individual contained antibodies that reacted with all RBCs from normal ABO phenotypes (i.e., groups O, A, B, and AB).
The individual’s RBCs appeared to lack all of the ABO blood group antigens and an additional antigen that was previously unknown.
In 1952, a paper about the “new blood group character related to the ABO blood group” was published.
This new blood group character is the H antigen and it is the building block for the antigens of the ABO blood group.
It was named for the city in which it was first discovered, the ‘Bombay phenotype’ describes individuals whose RBCs lack the H antigen.
Because the A and B antigens cannot be formed without the H antigen precursor, their RBCs also lack these antigens.
As a result, these individuals produce anti-H, anti-A, and anti-B and can thus be transfused only with RBCs that also lack the H, A, and B antigens i.e., they can only receive blood from another person with the Bombay phenotype.
Because of the rarity of this blood type, this normally means using blood donations from a suitable relative.

List of Blood Group Compatibility

S. No.	Blood Group	Antigens Present	Plasma Antibodies	Can Donate To (Recipients)	Can Receive From (Donors)
1.	O-	None	Anti-A, Anti-B	O-, O+, A-, A+, B-, B+, AB-, AB+ (Universal Donor)	O-
2.	O+	None (Rh+)	Anti-A, Anti-B	O+, A+, B+, AB+	O-, O+
3.	A-	A	Anti-B	A-, A+, AB-, AB+	O-, A-
4.	A+	A, Rh+	Anti-B	A+, AB+	O-, O+, A-, A+
5.	B-	B	Anti-A	B-, B+, AB-, AB+	O-, B-
6.	B+	B, Rh+	Anti-A	B+, AB+	O-, O+, B-, B+
7.	AB-	A, B	None	AB-, AB+	O-, A-, B-, AB-
8.	AB+	A, B, Rh+	None	AB+ only (Universal Recipient)	All types

Genetic Basis and Mechanism of the Bombay Blood Group Phenotype

The Bombay phenotype results from homozygous recessive inheritance of the h allele (hh genotype).
Normally, most people have at least one H allele, producing the H substance—a carbohydrate chain on red blood cell surfaces.
In Bombay individuals, the lack of H means no foundation for A or B sugars, so their cells appear “blank”.
However, their plasma forms with potent anti-H, anti-A, and anti-B antibodies, which agglutinate (clump) any non-Bombay blood introduced.
A related variant, the para-Bombay phenotype, retains some H antigen in secretions but not on cells, adding further complexity.

Prevalence Worldwide

Globally, the Bombay blood group affects about 0.0004% of people, or approximately 1 in 250,000 to 1 million.
In Mumbai, prevalence rises to about 1 in 10,000, linked to consanguineous marriages in western and southern India.
It is more common in India, Pakistan, Bangladesh, and some Middle Eastern pockets, though urbanization may dilute it through diverse gene pools.
Registries like those in Mumbai help track donors and are vital during medical emergencies.

Medical Challenges in Transfusions for the Bombay Blood Group

Bombay patients can donate to any ABO group since their cells lack A, B, or H antigens, acting as “universal donors” in that sense—but they cannot receive from anyone else.
O blood transfusion causes severe hemolytic reactions, including fever, chills, hemoglobinuria (red urine), and life-threatening renal failure from anti-H antibodies reacting with the O cells' H antigen.
Misdiagnosis as O is common without H-specific testing, leading to serious complications.
Only Bombay-to-Bombay transfusions are safe.
Kidney or liver transplants from non-Bombay patients also pose a risk of antibody incompatibility.

Conclusion

The Bombay blood group is a reflection of the genetic oddities of nature, but it also represents the challenges and triumphs of medical progress in the detection and registration of this rare condition. Through careful screening and networking, lives are protected. This universal enigma must transition from crisis to reality.

FAQs

What defines the Bombay blood group?

It is the hh phenotype lacking H antigen & appearing as O but with anti-H antibodies. The blood group was discovered in Mumbai in 1952.

Why can't Bombay patients receive O blood?

Their strong anti-H antibodies react with the H antigen of O blood, leading to severe hemolytic reactions such as fever and nephritis.

How rare is the Bombay blood group globally?

About 1 in 250,000-1 million people, higher in Mumbai at 1 in 10,000 due to genetic factors.

How is the Bombay blood group diagnosed?

Bombay blood group can be diagnosed with forward typing (no anti-H reaction), reverse typing (anti-H present), and genotyping for FUT1 mutations.

Can Bombay blood be given to other people?

Yes, because Bombay blood does not have A, B, or H antigens, it can be given to anyone regardless of their blood type. However, the recipient must have reverse compatibility.

What problems are encountered in organ transplants?

The presence of anti-H antibodies can cause rejection of non-Bombay organs such as the kidney or liver.

Are there registries for Bombay blood donors?

Yes, there is a National Rare Blood Donor Registry in India that helps patients find a compatible Bombay blood donor.